Cambridge Advisors Inc. reduced its holdings in shares of Cerner Co. (NASDAQ:CERN) by 2.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 39,740 shares of the company’s stock after selling 1,150 shares during the quarter. Cerner makes up 0.8% of Cambridge Advisors Inc.’s investment portfolio, making the stock its 23rd largest position. Cambridge Advisors Inc.’s holdings in Cerner were worth $2,274,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of the business. Essex Savings Bank acquired a new stake in shares of Cerner during the 4th quarter worth about $27,000. Moody National Bank Trust Division boosted its stake in shares of Cerner by 72.5% during the 1st quarter. Moody National Bank Trust Division now owns 483 shares of the company’s stock worth $28,000 after purchasing an additional 203 shares during the last quarter. JNBA Financial Advisors acquired a new stake in shares of Cerner during the 4th quarter worth about $34,000. Financial Gravity Companies Inc. acquired a new stake in shares of Cerner during the 4th quarter worth about $44,000. Finally, Lindbrook Capital LLC acquired a new stake in shares of Cerner during the 4th quarter worth about $62,000. Hedge funds and other institutional investors own 80.81% of the company’s stock.
Shares of CERN traded down $0.41 during mid-day trading on Tuesday, hitting $63.05. The company had a trading volume of 2,196,849 shares, compared to its average volume of 2,460,427. The company has a debt-to-equity ratio of 0.09, a quick ratio of 2.38 and a current ratio of 2.41. Cerner Co. has a 1-year low of $48.78 and a 1-year high of $67.57. The stock has a market capitalization of $20.58 billion, a PE ratio of 28.53, a P/E/G ratio of 1.96 and a beta of 0.97.
Several equities research analysts recently issued reports on CERN shares. Zacks Investment Research reissued a “sell” rating on shares of Cerner in a research report on Monday, December 31st. BidaskClub raised shares of Cerner from a “sell” rating to a “hold” rating in a research report on Wednesday, February 13th. Robert W. Baird raised their target price on shares of Cerner from $67.00 to $71.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 10th. SunTrust Banks raised shares of Cerner from a “hold” rating to a “buy” rating and raised their target price for the stock from $60.00 to $76.00 in a research report on Wednesday, April 10th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $75.00 target price on shares of Cerner in a research report on Tuesday, April 9th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the stock. Cerner has an average rating of “Buy” and an average price target of $68.67.
TRADEMARK VIOLATION NOTICE: “Cambridge Advisors Inc. Sells 1,150 Shares of Cerner Co. (CERN)” was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2019/04/16/cambridge-advisors-inc-sells-1150-shares-of-cerner-co-cern.html.
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.